IGP-002

N/A

Report date: 2025/01/26 18:42:05
NME

Base Information

Drug NameIGP-002
Drug Alias NameIGP-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionc-Jun N-terminal kinase inhibitors
Targetsc-Jun N-terminal kinase
Therapy Area/IndicationsParkinson DiseaseIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImago Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesImago Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsParkinson DiseaseIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A